(Q48092361)

8 February 2018

title

Triple-dose versus single-dose gadoteridol in multiple sclerosis patients (English)

1 reference

8 February 2018

0 references

Wolansky LJ

1

1 reference

8 February 2018

Bardini JA

2

1 reference

8 February 2018

Cook SD

3

1 reference

8 February 2018

Zimmer AE

4

1 reference

8 February 2018

Sheffet A

5

1 reference

8 February 2018

Lee HJ

6

1 reference

8 February 2018

publication date

1 July 1994

1 reference

8 February 2018

published in

Journal of Neuroimaging

1 reference

8 February 2018

volume

4

1 reference

8 February 2018

issue

3

1 reference

8 February 2018

page(s)

141-145

1 reference

8 February 2018

High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases. Tolerance of the contrast agent.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Expanded High Iodine Dose in Computed Cranial Tomography: A Preliminary Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

High-dose gadoteridol in MR imaging of intracranial neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

High-dose applications of gadolinium chelates in magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

CT of multiple sclerosis: reassessment of delayed scanning with high doses of contrast material.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJON199443141

21 January 2018

Identifiers

DOI

10.1111/JON199443141

1 reference

8 February 2018

1 reference

8 February 2018